ロード中...
Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder
Whole-genome sequencing (WGS) has facilitated the first genome-wide evaluations of the contribution of de novo noncoding mutations to complex disorders. Using WGS, we assess genetic variation from 7,608 samples in 1,902 autism spectrum disorder (ASD) families, identifying 255,106 de novo mutations....
保存先:
| 出版年: | Science |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6432922/ https://ncbi.nlm.nih.gov/pubmed/30545852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.aat6576 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|